Ukraine MoH signs “understanding” with insulin producers

On March 19, Oleg Musiy, the Minister of Health in Ukraine, signed the memorandum of understanding with representatives of pharmaceutical companies and authorized representatives of foreign insulin producers: Farmak JSC, INDAR PrJSC, PharmaLife and two Association of Pharmaceutical Research and Development (APRaD) member companies – the USA’s Eli Lilly (NYSE: LLY) and France’s Sanofi (Euronext: SAN).

Guided by the basic principles of partnership between business and government, the signatories agreed on the need for joint measures to stabilize the price of insulin realizing the necessity of collaboration to supply patients with medicines within targeted local spending on the free provision of insulin for diabetics, according to a statement by the APRaD, the trade group representing the research-based pharma industry in Ukraine. The Memorandum is open to accession by other insulin producers, it noted.